Erasme Scientific Publications

Erasme Scientific Publications

  • Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy.

  • Auteurs Julian E, Xander NSH, Boumaki K, Garcia MJ, Jahimovica E, Mosset-Keane J, Otto MH, Pavlovic M, Scroccaro G, Strammiello V, Bernardini R, Capri S, Casado-Arroyo R, Desmet T, Van Dyck W, Fricke FU, Gianfrate F, Solà-Morales O, Wasem J, Wörmann BJ, Ruof J
  • Revue J Mark Access Health Policy
  • Date de publication 2026-03
Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy.
  • Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Baseline Characteristics, Drug Exposure, and Outcomes in an Exploratory Analysis From ODYSSEY-HCM.

  • Auteurs Desai MY, Owens A, Garcia-Pavia P, Abraham T, Nissen SE, Chevalier P, Wang A, De Souza J, Bach R, Bondue A, Gong Z, Aronson R, Florea V, Olivotto I
  • Revue J Am Coll Cardiol
  • Date de publication 2026-03
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Baseline Characteristics, Drug Exposure, and Outcomes in an Exploratory Analysis From ODYSSEY-HCM.
  • Electrophysiology Consumables Procurement in Europe: Implications for Access, Innovation and Value-Based Care.

  • Auteurs Osoro L, Kozhuharov N, Landen R, Arbelo E, Martinek M, Leclerq C, Fauchier L, Deharo JC, Boveda S, Sommer P, Rienstra M, Szymanski P, Farkowski M, Costa F, Tint D, Simovic S, Dzhinsov K, Leyva F, Boriani G, Figueras J, Ihara Z, Merino JL, Burri H, Pürerfellner H, Casado-Arroyo R
  • Revue Europace
  • Date de publication 2026-03
Electrophysiology Consumables Procurement in Europe: Implications for Access, Innovation and Value-Based Care.
  • Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.

  • Auteurs Gomberg-Maitland M, Tedford RJ, Langleben D, Rosenkranz S, Miller B, Jones AD, Urbinati A, McMullan CJ, Cornell AG, Vachiery JL
  • Revue Circulation
  • Date de publication 2026-03
Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
  • Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

  • Auteurs Ogbogu PU, Roufosse F, Akuthota P, Kuna P, Groh M, Reiter A, Yokota A, Siddiqui SH, Mutsaers PGNJ, Li B, Khoury P, Bahadori LM, Bednarczyk A, Bouma G, Brooks LG, Ferreira J, Grindebacke H, Ho CN, Jain P, Palmer RL, Jison ML, Klion AD
  • Revue Nat Med
  • Date de publication 2026-03
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.
Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Decorative image of doctor and patient

All scientific publications by the H.U.B.

View all scientific publications from the H.U.B.